Gata4-dependent differentiation of c-Kit+-derived endothelial cells underlies artefactual cardiomyocyte regeneration in the heart

Circulation

Volumn 138, Issue 10, 2018, Pages 1012-1024

  Maliken, Bryan D ^a   Kanisicak, Onur ^a   Karch, Jason ^a   Khalil, Hadi ^a   Fu, Xing ^a   Boyer, Justin G ^a,b   Prasad, Vikram ^a   Zheng, Yi ^a   Molkentin, Jeffery D ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Angiogenesis; Mice, transgenic; Myocardial infarction; Myocytes, cardiac; Regeneration

Indexed keywords

GREEN FLUORESCENT PROTEIN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; STEM CELL FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; VASCULOTROPIN A; GATA4 PROTEIN, MOUSE; GATA6 PROTEIN, MOUSE; STEM CELL FACTOR RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HETEROZYGOSITY; INDUCED PLURIPOTENT STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANGIOGENESIS; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL FUSION; CELL LINEAGE; CELL TRACKING; ENDOTHELIUM CELL; FEMALE; GENETICS; KNOCKOUT MOUSE; LEUKOCYTE; MALE; METABOLISM; PROCEDURES; REGENERATION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL FUSION; CELL LINEAGE; CELL PROLIFERATION; CELL TRACKING; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GATA4 TRANSCRIPTION FACTOR; GATA6 TRANSCRIPTION FACTOR; LEUKOCYTES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; REGENERATION; SIGNAL TRANSDUCTION;

EID: 85049270138     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.118.033703     Document Type: Article

References (60)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Cir-culation. 2011;125:e2-e220. doi:10.1161/CIR.0b013e31823ac046
2. Toldo S, Abbate A. The NLRP3 infammasome in acute myocardial infarction. Nat Rev Cardiol. 2018;15:203-214. doi: 10.1038/nrcardio.2017.161.
3. Talman V, Ruskoaho H. Cardiac fbrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016;365:563-581. doi: 10.1007/s00441-016-2431-9
4. Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, Brody MJ, J Lin SC, Aronow BJ, Tallquist MD, Molkentin JD. Genetic lineage tracing defnes myofbroblast origin and function in the injured heart. Nat Com-mun. 2016;7:12260. doi: 10.1038/ncomms12260
5. Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, Karch J, Molkentin JD. Fibroblast-specifc TGF-β-Smad2/3 signaling underlies cardiac fbrosis. J Clin Invest. 2017;127:3770-3783. doi: 10.1172/JCI94753
6. Saxena A, Bujak M, Frunza O, Dobaczewski M, Gonzalez-Quesada C, Lu B, Gerard C, Frangogiannis NG. CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fbroblasts are mediated through proteoglycans. Cardiovasc Res. 2014;103:217-227. doi: 10.1093/cvr/cvu138
7. Berry C, Balachandran K P, L'Allier PL, Lespérance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur Heart J. 2007;28:278-291. doi: 10.1093/eurheartj/ehl446
8. Zimarino M, D'Andreamatteo M, Waksman R, Epstein SE, De Caterina R. The dynamics of the coronary collateral circulation. Nat Rev Cardiol. 2014;11:191-197. doi: 10.1038/nrcardio.2013.207
9. Senyo SE, Lee RT, Kühn B. Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. Stem Cell Res. 2014;13(3 pt B):532-541. doi: 10.1016/j.scr.2014.09.003
10. Kawaguchi N, Nakanishi T. Cardiomyocyte regeneration. Cells. 2013;2:67-82. doi: 10.3390/cells2010067
11. Lu L, Li F, Lu J. Identifcation of functional tissue-resident cardiac stem/progenitor cells in adult mouse. Cell Biol Int Rep (2010). 2012;19:e00016. doi: 10.1042/CBR20120001
12. Bollini S, Smart N, Riley PR. Resident cardiac progenitor cells: at the heart of regeneration. J Mol Cell Cardiol. 2011;50:296-303. doi: 10.1016/j.yjmcc.2010.07.006
13. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116:1865-1877. doi: 10.1172/JCI27019
14. Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration. Am J Cardiovasc Dis. 2012;2:58-67.
15. Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J, Fisher PJ, Steffey M, Hesse M, Doran RM, Woods A, Singh B, Yen A, Fleischmann BK, Kotlikoff MI. c-kit expression identifes cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA. 2009;106:1808-1813. doi: 10.1073/pnas.0808920106
16. Beltrami A P, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasa-hara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocar-dial regeneration. Cell. 2003;114:763-776.
17. Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP; DAMASCENE writing group. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014;348:g2688.
18. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and in-duces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126:551-568. doi: 10.1161/CIRCULATIONAHA.111.086074
19. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fbrosis in ischemic mouse heart. J Mol Cell Cardiol. 2003;35:1113-1119.
20. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goich-berg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardio-myopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-1857. doi: 10.1016/S0140-6736(11)61590-0
21. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R. Administration of cardiac stem cells in patients with ischemic cardiomy-opathy: the SCIPIO trial: surgical aspects and interim analysis of myocardi-al function and viability by magnetic resonance. Circulation. 2012;126(11 suppl 1):S54-S64. doi: 10.1161/CIRCULATIONAHA.112.092627
22. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, Middleton RC, Marbán E, Molkentin JD. c-kit+ cells minimally contribute cardiomyo-cytes to the heart. Nature. 2014;509:337-341. doi: 10.1038/nature13309
23. Sultana N, Zhang L, Yan J, Chen J, Cai W, Razzaque S, Jeong D, Sheng W, Bu L, Xu M, Huang GY, Hajjar RJ, Zhou B, Moon A, Cai CL. Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat Commun. 2015;6:8701. doi: 10.1038/ncomms9701
24. He L, Li Y, Li Y, Pu W, Huang X, Tian X, Wang Y, Zhang H, Liu Q, Zhang L, Zhao H, Tang J, Ji H, Cai D, Han Z, Han Z, Nie Y, Hu S, Wang QD, Sun R, Fei J, Wang F, Chen T, Yan Y, Huang H, Pu WT, Zhou B. Enhancing the precision of genetic lineage tracing using dual recombinases. Nat Med. 2017;23:1488-1498. doi: 10.1038/nm.4437
25. Chen Z, Zhu W, Bender I, Gong W, Kwak IY, Yellamilli A, Hodges TJ, Nemo-to N, Zhang J, Garry DJ, van Berlo JH. Pathologic stimulus determines lineage commitment of cardiac c-kit+ cells. Circulation. 2017;136:2359-2372. doi: 10.1161/CIRCULATIONAHA.117.030137
26. Kannappan R, Matsuda A, Ferreira-Martins J, Zhang E, Palano G, Czarna A, Cabral-Da-Silva MC, Bastos-Carvalho A, Sanada F, Ide N, Rota M, Blas-co MA, Serrano M, Anversa P, Leri A. p53 modulates the fate of cardiac progenitor cells ex vivo and in the diabetic heart in vivo. EBioMedicine. 2017;16:224-237. doi: 10.1016/j.ebiom.2017.01.028
27. Zhao R, Watt AJ, Battle MA, Li J, Bondow BJ, Duncan SA. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol. 2008;317:614-619. doi: 10.1016/j.ydbio.2008.03.013
28. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molken-tin JD. Cardiac-specifc deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. 2006;98:837-845. doi: 10.1161/01.RES.0000215985.18538.c4
29. van Berlo JH, Aronow BJ, Molkentin JD. Parsing the roles of the tran-scription factors GATA-4 and GATA-6 in the adult cardiac hypertrophic response. PLoS One. 2013;8:e84591. doi: 10.1371/journal.pone.0084591
30. Feng Y, Liu M, Guo F, Liu W, Sampson L, You L-R, Kuan C-Y, Zheng Y. Novel method to study mouse bone marrow endothelial cells in vivo and in vitro. Blood. 2012;120:617.
31. Karch J, Schips TG, Maliken BD, Brody MJ, Sargent MA, Kanisi-cak O, Molkentin JD. Autophagic cell death is dependent on lyso-somal membrane permeability through Bax and Bak. eLife. 2017;6. doi:10.7554/eLife.30543
32. Cui YZ, Hisha H, Yang GX, Fan TX, Jin T, Li Q, Lian Z, Ikehara S. Optimal protocol for total body irradiation for allogeneic bone marrow trans-plantation in mice. Bone Marrow Transplant. 2002;30:843-849. doi: 10.1038/sj.bmt.1703766
33. Accornero F, Schips TG, Petrosino JM, Gu SQ, Kanisicak O, van Berlo JH, Molkentin JD. BEX1 is an RNA-dependent mediator of cardiomyopathy. Nat Commun. 2017;8:1875. doi: 10.1038/s41467-017-02005-1
34. Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, Sriv-astava D, Garg V. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol. 2009;326:368-377. doi: 10.1016/j.ydbio.2008.11.004
35. Xin M, Davis CA, Molkentin JD, Lien CL, Duncan SA, Richardson JA, Olson EN. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci USA. 2006;103:11189-11194. doi: 10.1073/pnas.0604604103
36. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fuorescent Cre reporter mouse. Genesis. 2007;45:593-605. doi: 10.1002/dvg.20335
37. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901-904. doi: 10.1038/nature01539
38. Camargo FD, Finegold M, Goodell MA. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest. 2004;113:1266-1270. doi: 10.1172/JCI21301
39. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;425:968-973. doi: 10.1038/nature02069
40. Nygren JM, Jovinge S, Breitbach M, Säwén P, Röll W, Hescheler J, Ta-neera J, Fleischmann BK, Jacobsen SE. Bone marrow-derived hemato-poietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10:494-501. doi: 10.1038/nm1040
41. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. AC133, a novel marker for human hema-topoietic stem and progenitor cells. Blood. 1997;90:5002-5012.
42. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by pro-moting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234. doi: 10.1038/ncb1486
43. Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovasc Res. 2010;87:262-271. doi: 10.1093/cvr/cvq105
44. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejew-ski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
45. Hakanpaa L, Sipila T, Leppanen VM, Gautam P, Nurmi H, Jacquemet G, Eklund L, Ivaska J, Alitalo K, Saharinen P. Endothelial destabilization by angiopoietin-2 via integrin β1 activation. Nat Commun. 2015;6:5962. doi: 10.1038/ncomms6962
46. Rivera-Feliciano J, Lee KH, Kong SW, Rajagopal S, Ma Q, Springer Z, Izumo S, Tabin CJ, Pu WT. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development. 2006;133:3607-3618. doi: 10.1242/dev.02519
47. Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, Löfqvist C, Hellström A, Smith LE. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51:2813-2826. doi: 10.1167/iovs.10-5176
48. Ho M, Yang E, Matcuk G, Deng D, Sampas N, Tsalenko A, Tabibiazar R, Zhang Y, Chen M, Talbi S, Ho YD, Wang J, Tsao PS, Ben-Dor A, Yakhini Z, Bruhn L, Quertermous T. Identifcation of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics. 2003;13:249-262. doi: 10.1152/physiolgenomics.00186.2002
49. Manuylov NL, Tevosian SG. Cardiac expression of Tnnt1 requires the GATA4-FOG2 transcription complex. Scientifc World Journal. 2009;9:575-587. doi: 10.1100/tsw.2009.75
50. Zhou B, Ma Q, Kong SW, Hu Y, Campbell PH, McGowan FX, Ackerman KG, Wu B, Zhou B, Tevosian SG, Pu WT. Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart. J Clin Invest. 2009;119:1462-1476. doi: 10.1172/JCI38723
51. Dai YS, Cserjesi P, Markham BE, Molkentin JD. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J Biol Chem. 2002;277:24390-24398. doi: 10.1074/jbc.M202490200
52. Stennard FA, Costa MW, Elliott DA, Rankin S, Haast SJ, Lai D, McDonald LP, Niederreither K, Dolle P, Bruneau BG, Zorn AM, Harvey R P. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol. 2003;262:206-224.
53. Pei Y, Yao Q, Yuan S, Xie B, Liu Y, Ye C, Zhuo H. GATA4 promotes hepato-blastoma cell proliferation by altering expression of miR125b and DKK3. Oncotarget. 2016;7:77890-77901. doi: 10.18632/oncotarget.12839
54. Holtzinger A, Rosenfeld GE, Evans T. Gata4 directs development of car-diac-inducing endoderm from ES cells. Dev Biol. 2010;337:63-73. doi: 10.1016/j.ydbio.2009.10.003
55. Manuylov NL, Fujiwara Y, Adameyko II, Poulat F, Tevosian SG. The regulation of Sox9 gene expression by the GATA4/FOG2 transcriptional complex in dominant XX sex reversal mouse models. Dev Biol. 2007;307:356-367. doi: 10.1016/j.ydbio.2007.04.040
56. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfster O, Cui L, Kumar A, Lin Z, Sen-Banerjee S, Das H, Petersen CA, Mende U, Burleigh BA, Zhu Y, Pinto YM, Pinto Y, Liao R, Jain MK. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA. 2007;104:7074-7079. doi: 10.1073/pnas.0701981104
57. Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, Mc-Dermott MG, Ma'ayan A. The harmonizome: a collection of processed da-tasets gathered to serve and mine knowledge about genes and proteins. Database. 2016. doi:10.1093/database/baw100
58. Karkkainen MJ, Petrova T V. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene. 2000;19:5598-5605. doi: 10.1038/sj.onc.1203855
59. Liu Q, Yang R, Huang X, Zhang H, He L, Zhang L, Tian X, Nie Y, Hu S, Yan Y, Zhang L, Qiao Z, Wang QD, Lui KO, Zhou B. Genetic lineage tracing identifes in situ Kit-expressing cardiomyocytes. Cell Res. 2016;26:119-130. doi: 10.1038/cr.2015.143
60. Géraud C, Koch PS, Zierow J, Klapproth K, Busch K, Olsavszky V, Leibing T, Demory A, Ulbrich F, Diett M, Singh S, Sticht C, Breitkopf-Heinlein K, Richter K, Karppinen SM, Pihlajaniemi T, Arnold B, Rodewald HR, Augustin HG, Schledzewski K, Goerdt S. GATA4-dependent organ-specifc endo-thelial differentiation controls liver development and embryonic hemato-poiesis. J Clin Invest. 2017;127:1099-1114. doi: 10.1172/JCI90086